Human Embryonic Stem Cells (hESC) Market to Reach $1 Billion by 2025 - Application of hESCs as a Promising Donor Source for Cellular Transplantation to Drive Growth - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Human Embryonic Stem Cells (hESC) Market, 2014 - 2025" report to their offering.

The global human embryonic stem cells (hESCs) market is anticipated to reach USD 1.06 billion by 2025. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft.

Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.

In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.

Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.

However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.

Companies Mentioned

  • Astellas Pharma Inc/ Ocata Therapeutics
  • STEMCELL Technologies Inc.
  • BIOTIME, INC. / Cell Cure Neurosciences LTD
  • Thermo Fisher Scientific, Inc.
  • CellGenix GmbH
  • ESI BIO
  • PromoCell GmbH
  • Lonza
  • Kite Pharma
  • Cynata
  • Sumanas, Inc.
  • LifeCell
  • International Stem Cell Corporation
  • Cordlife
  • Genea BioCells
  • Geron

Key Topics Covered:

1 Research Methodology

2 Executive Summary

3 Human Embryonic Stem Cells Market Variables, Trends & Scope

4 Human Embryonic Stem Cells Market: Application Estimates & Trend Analysis

5 Human Embryonic Stem Cells Market: Regional Estimates & Trend Analysis, by Application

6 Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/w7n75n/human_embryonic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Stem Cells

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Stem Cells